DRAP grants permission to another Chinese firm to conduct clinical trials of COVID vaccine
- Anhui Zhifei longcom will conduct its trials in Karachi at a private hospital, while in Lahore at the University of Health Sciences and another private health facility
- At least 9,000 volunteers will participate in clinical trials of the Anhui Zhifei vaccine across the country